This page provides information on current National Pathology Accreditation Advisory Committee (NPAAC) activities.

Page last updated: 20 April 2020

COVID Point of Care Testing

NPAAC provides advice and quality standards for pathology testing that is risk based with the aim of mitigating potential risks to patient safety.

To support the increase in testing demand for COVID-19, NPAAC has provided some guidance on key considerations that are applicable to PoCT used in healthcare settings.

Documents for Review

NPAAC has commenced the development of the following new accreditation standards and would welcome any comments or supporting documentation that may inform the consideration process:
    • Requirements for the Communication of High Risk Pathology Results
    • Requirements for Digital Images as an Alternative to Direct Microscopy
NPAAC has commenced reviews on the following standards and welcome any comments that may inform the document review process:
    • Requirements for Information Communication
    • Guidelines for Point of Care Testing
    • Requirements for Medical Testing of Human Nucleic Acids
    • Requirements for Cytogenetic Testing
    • Guidelines for Approved Pathology Collection Centres (Requirements for Medical Pathology Specimen Collection
    • Requirements for the Facilities and Operations of Mortuaries
    • The Provision of Direct-to-Consumer Genetic Testing Guiding Principles for Providers
Should you have any queries or wish to provide comments to inform document reviews, please email the NPAAC Secretariat.